vs
Side-by-side financial comparison of NovoCure Ltd (NVCR) and PREFORMED LINE PRODUCTS CO (PLPC). Click either name above to swap in a different company.
NovoCure Ltd is the larger business by last-quarter revenue ($174.1M vs $173.1M, roughly 1.0× PREFORMED LINE PRODUCTS CO). PREFORMED LINE PRODUCTS CO runs the higher net margin — 4.9% vs -40.9%, a 45.7% gap on every dollar of revenue. On growth, NovoCure Ltd posted the faster year-over-year revenue change (12.3% vs 3.6%). Over the past eight quarters, PREFORMED LINE PRODUCTS CO's revenue compounded faster (10.8% CAGR vs 7.6%).
NovoCure Ltd is a global oncology company that develops and commercializes innovative Tumor Treating Fields (TTFields) therapy, a non-invasive wearable treatment using low-intensity electric fields to disrupt cancer cell division. Its approved therapies target glioblastoma, malignant mesothelioma and non-small cell lung cancer, serving patients across North America, Europe and Asia Pacific.
Preformed Line Products Co (PLPC) designs, manufactures and supplies engineered hardware for power transmission, telecommunications, and renewable energy infrastructure sectors. It serves utility, network operator and industrial customers across global regions, offering solutions that boost network reliability and operational efficiency.
NVCR vs PLPC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $174.1M | $173.1M |
| Net Profit | $-71.1M | $8.4M |
| Gross Margin | 77.6% | 29.8% |
| Operating Margin | — | 6.8% |
| Net Margin | -40.9% | 4.9% |
| Revenue YoY | 12.3% | 3.6% |
| Net Profit YoY | -107.3% | -19.3% |
| EPS (diluted) | — | $1.72 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $174.1M | — | ||
| Q4 25 | $174.3M | $173.1M | ||
| Q3 25 | $167.2M | $178.1M | ||
| Q2 25 | $158.8M | $169.6M | ||
| Q1 25 | $155.0M | $148.5M | ||
| Q4 24 | $161.3M | $167.1M | ||
| Q3 24 | $155.1M | $147.0M | ||
| Q2 24 | $150.4M | $138.7M |
| Q1 26 | $-71.1M | — | ||
| Q4 25 | $-24.5M | $8.4M | ||
| Q3 25 | $-37.3M | $2.6M | ||
| Q2 25 | $-40.1M | $12.7M | ||
| Q1 25 | $-34.3M | $11.5M | ||
| Q4 24 | $-65.9M | $10.5M | ||
| Q3 24 | $-30.6M | $7.7M | ||
| Q2 24 | $-33.4M | $9.4M |
| Q1 26 | 77.6% | — | ||
| Q4 25 | 75.8% | 29.8% | ||
| Q3 25 | 73.2% | 29.7% | ||
| Q2 25 | 73.9% | 32.7% | ||
| Q1 25 | 75.1% | 32.8% | ||
| Q4 24 | 79.2% | 33.3% | ||
| Q3 24 | 77.2% | 31.1% | ||
| Q2 24 | 77.0% | 31.9% |
| Q1 26 | — | — | ||
| Q4 25 | -23.2% | 6.8% | ||
| Q3 25 | -21.5% | 7.4% | ||
| Q2 25 | -24.9% | 10.1% | ||
| Q1 25 | -24.4% | 8.8% | ||
| Q4 24 | -39.3% | 10.5% | ||
| Q3 24 | -20.7% | 7.1% | ||
| Q2 24 | -22.3% | 8.1% |
| Q1 26 | -40.9% | — | ||
| Q4 25 | -14.1% | 4.9% | ||
| Q3 25 | -22.3% | 1.5% | ||
| Q2 25 | -25.3% | 7.5% | ||
| Q1 25 | -22.1% | 7.8% | ||
| Q4 24 | -40.9% | 6.3% | ||
| Q3 24 | -19.7% | 5.2% | ||
| Q2 24 | -22.2% | 6.8% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.22 | $1.72 | ||
| Q3 25 | $-0.33 | $0.53 | ||
| Q2 25 | $-0.36 | $2.56 | ||
| Q1 25 | $-0.31 | $2.33 | ||
| Q4 24 | $-0.61 | $2.13 | ||
| Q3 24 | $-0.28 | $1.54 | ||
| Q2 24 | $-0.31 | $1.89 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $432.0M | — |
| Total DebtLower is stronger | — | $38.3M |
| Stockholders' EquityBook value | $330.7M | $475.5M |
| Total Assets | $787.9M | $653.6M |
| Debt / EquityLower = less leverage | — | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $432.0M | — | ||
| Q4 25 | $93.5M | — | ||
| Q3 25 | $342.1M | — | ||
| Q2 25 | $149.6M | — | ||
| Q1 25 | $127.3M | — | ||
| Q4 24 | $163.8M | — | ||
| Q3 24 | $185.4M | — | ||
| Q2 24 | $164.8M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $38.3M | ||
| Q3 25 | — | $36.0M | ||
| Q2 25 | — | $31.8M | ||
| Q1 25 | — | $29.1M | ||
| Q4 24 | — | $20.8M | ||
| Q3 24 | — | $27.2M | ||
| Q2 24 | — | $31.6M |
| Q1 26 | $330.7M | — | ||
| Q4 25 | $340.5M | $475.5M | ||
| Q3 25 | $341.3M | $466.3M | ||
| Q2 25 | $349.4M | $460.7M | ||
| Q1 25 | $362.0M | $435.8M | ||
| Q4 24 | $360.2M | $422.3M | ||
| Q3 24 | $360.8M | $429.0M | ||
| Q2 24 | $361.8M | $416.2M |
| Q1 26 | $787.9M | — | ||
| Q4 25 | $804.3M | $653.6M | ||
| Q3 25 | $1.4B | $644.6M | ||
| Q2 25 | $1.2B | $631.5M | ||
| Q1 25 | $1.2B | $592.5M | ||
| Q4 24 | $1.2B | $573.9M | ||
| Q3 24 | $1.2B | $592.0M | ||
| Q2 24 | $1.2B | $572.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.08× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | 0.07× | ||
| Q4 24 | — | 0.05× | ||
| Q3 24 | — | 0.06× | ||
| Q2 24 | — | 0.08× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $21.9M |
| Free Cash FlowOCF − Capex | — | $11.8M |
| FCF MarginFCF / Revenue | — | 6.8% |
| Capex IntensityCapex / Revenue | — | 5.9% |
| Cash ConversionOCF / Net Profit | — | 2.60× |
| TTM Free Cash FlowTrailing 4 quarters | — | $33.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-18.0M | $21.9M | ||
| Q3 25 | $20.6M | $18.9M | ||
| Q2 25 | $-15.9M | $26.9M | ||
| Q1 25 | $-35.7M | $5.7M | ||
| Q4 24 | $-3.5M | $24.1M | ||
| Q3 24 | $10.4M | $9.4M | ||
| Q2 24 | $-1.7M | $28.3M |
| Q1 26 | — | — | ||
| Q4 25 | $-22.9M | $11.8M | ||
| Q3 25 | $14.9M | $8.3M | ||
| Q2 25 | $-21.4M | $18.6M | ||
| Q1 25 | $-46.3M | $-5.3M | ||
| Q4 24 | $-12.4M | $20.6M | ||
| Q3 24 | $-307.0K | $5.8M | ||
| Q2 24 | $-13.2M | $24.6M |
| Q1 26 | — | — | ||
| Q4 25 | -13.1% | 6.8% | ||
| Q3 25 | 8.9% | 4.7% | ||
| Q2 25 | -13.5% | 10.9% | ||
| Q1 25 | -29.9% | -3.6% | ||
| Q4 24 | -7.7% | 12.3% | ||
| Q3 24 | -0.2% | 3.9% | ||
| Q2 24 | -8.8% | 17.7% |
| Q1 26 | — | — | ||
| Q4 25 | 2.8% | 5.9% | ||
| Q3 25 | 3.4% | 6.0% | ||
| Q2 25 | 3.5% | 4.9% | ||
| Q1 25 | 6.8% | 7.4% | ||
| Q4 24 | 5.5% | 2.1% | ||
| Q3 24 | 6.9% | 2.4% | ||
| Q2 24 | 7.6% | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.60× | ||
| Q3 25 | — | 7.21× | ||
| Q2 25 | — | 2.12× | ||
| Q1 25 | — | 0.49× | ||
| Q4 24 | — | 2.30× | ||
| Q3 24 | — | 1.22× | ||
| Q2 24 | — | 3.02× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
